CTH.L Share News (CTH)
CTH Share
CTH Share
CTH Share
CTH Share
CTH
CTH Share
CTH Broker
CTH Directors
CTH Financial
CTH
CTH Short
CTH
ASOS: Panmure Gordon raises target price from 4555p to 5950p maintaining a buy recommendation. AstraZeneca: Jefferies reduces target price from 3200p to 2850p and retains a hold recommendation. Barclays: Jefferies initiates with a target price of 367p and a buy recommendation. Barratt Development
Read moreCareTech, the AIM-listed social care services firm, announced Wednesday that both its Executive Chairman and Chief Executive Officer each purchased 485,000 shares. Farouq Sheikh and Haroon Sheikh both paid 190p a share, costing a total of £921,500. The purchases were announced the same day the c
Read moreCareTech, the AIM-listed social care services firm, is hoping to save substantial costs in rental charges after the acquisition of two property portfolios. The company said on Wednesday that it has bought the freeholds of the portfolios, comprising 29 properties in total, for £38m. "The board res
Read moreAfrican Barrick Gold: Citi moves target price from 175p to 124p and maintains a sell recommendation. ASOS: Nomura raises target price from 2970p to 3400p keeping a neutral rating. Exane increases target price from 4200p to 5000p and retains its outperform rating. Citi ups target price from 4400p to
Read moreTempus in The Times writes that one company that has had a difficult couple of years is CareTech Holdings, the AIM-quoted provider of specialist care homes. There was a bizarre row over a policy of capitalising the salaries of members of staff seeking acquisitions. At least one bid and one managem
Read moreRevenue rose 4.5 per cent to 114.1m pounds in the year ending September 30th 2012 at CareTech, boosted by underlying pre-tax profit, which climbed 5.0 per cent to 16.7m pounds. Overall capacity at its facilities increase by 110 places to 2,166, while its property portfolio was independently valued
Read moreAlthough December tends to be one of the best months of the year for stocks next week's calendar comes replete with potentially market moving events and at least one potential 'tipping point, ' which markets will need to navigate. George Osborne will present his Autumn Statement on December 5th,
Read moreAshtead: UBS raises target from 375p to 400p, buy rating kept. ASOS: Panmure Gordon keeps buy rating and 2,530p target. AZ Electronic Materials: Goldman Sachs upgrades to conviction buy. Booker: Panmure Gordon keeps buy rating and 108p target. Britvic: Panmure Gordon keeps hold rating and 380p t
Read moreCareTech has provided a positive trading update for the full year ending September 30th, stating that "trading for the full year will be in line with its expectations". Consensus estimates for the year ended September 30th are for pre-tax profits of £16.74m on turnover of £116.56m. Earlier this ye
Read moreAberdeen Asset Management: Societe Generale upgrades to buy from hold. Aggreko: S&P Equity Research upgrades to buy. BT Group: Societe Generale raises target from 210p to 220p, hold rating kept. CareTech: Canaccord Genuity ups target from 166p to 194p, buy rating kept. Carpetright: Merchant Secu
Read moreCareTech Holdings, a UK provider of specialist social care services, has successfully completed the refinancing of its banking facilities, which were due to expire in April 2013. The new facilities total £149.4m, comprising a term loan, a revolving credit facility and an overdraft facility for wor
Read moreATUK, the cloud e-Commerce marketplace, has announced it is working with Visa to establish a new business-to-business partnership. The aim is to enhance the value of commercial payment solutions in the Asia Pacific, Central Europe, Middle East and Africa regions. Geosciences firm GETECH, which spe
Read moreBritish Land: Credit Suisse downgrades to neutral from outperform, target cut to 532p from 560p. Barclays: UBS raises target from 199p to 240p, neutral rating kept. Shore Capital upgrades to neutral from sell. Exane BNP upgrades to overweight from neutral. Standard Life: Nomura raises target from
Read moreSports nutrition specialist Provexis said an industrial scale production of Fruitflow powder, was successfully completed in 2012. Fruitflow is Provexis's tomato extract which inhibits platelet aggregating and therefore reduces the chance of heart disease. Provexis has identified a potential applic
Read moreAshmore: Barclays upgrades to overweight from neutral. Glencore: UBS cuts target from 530p to 490p, buy rating unchanged. Vodafone: Nomura reiterates buy rating and 230p target. Britvic: Nomura keeps buy recommendation and 425p target; Collins Stewart gives sell rating and 290p target. WH Smit
Read more
